Safety and Performance of the SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchors in Shoulder and Hip Arthroscopic Repair

NCT ID: NCT03691298

Last Updated: 2025-01-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

83 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-07

Study Completion Date

2021-05-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The scientific justification is to fulfill post-market clinical requirements in order to support re-certification of the CE-Mark for this marketed product and to look into safety and efficacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Shoulder: The superior labrum (fibrous cartilage) and biceps anchor improve joint stability by acting like a secondary stabilizer to the shoulder. Labral injuries are usually associated with anterior shoulder dislocation. When conservative treatment fails, such as physical therapy, strengthening programs, anti-inflammatories and activity modification to improve symptoms, surgical intervention may be required. Surgical treatments can include simple debridement, stabilization of the biceps-labrum complex through repair, or biceps tenodesis where the end of a tendon is joined surgically to the bone. Outcomes of SLAP (superior labral tear from anterior to posterior) repairs have been reported good throughout the literature, with reported success rates ranging from 71-97%.

Hip: The labrum of the hip is a fibrocartilaginous tissue that connects to the bone edge of the acetabulum (the socket of the hip bone), and deepens the acetabular socket while extending coverage of the femoral head; it also aids in hip stabilization. The goal of surgical intervention is to restore normal hip mechanics and treat existing damage.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Instability, Joint

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arthroscopic hip and shoulder repair

SUTUREFIX ULTRA Suture Anchor and SUTUREFIX CURVED Suture Anchor

Intervention Type DEVICE

Fixation device intended to provide secure fixation of soft tissue to bone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SUTUREFIX ULTRA Suture Anchor and SUTUREFIX CURVED Suture Anchor

Fixation device intended to provide secure fixation of soft tissue to bone

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has consented to participate in the study by signing the EC-approved informed consent form
* Subject condition meets proposed indication to SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchor
* Subject requiring shoulder or hip arthroscopic labral repair surgery from physical findings, subject symptoms and radiographic finding
* Hip subjects only:

* FAI (Femoroacetabular Impingement)
* Shoulder subjects only:

* Subject with a history of recurrent dislocation/subluxation of the shoulder

Exclusion Criteria

* Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1 (pre-operative)
* Women who are pregnant, nursing, or of child-bearing potential who are not utilizing highly effective birth control measures
* Contraindications or hypersensitivity to the use of the SUTUREFIX ULTRA and/or SUTUREFIX CURVED Suture Anchor, or their components (e.g. silicone, polyester). Where material sensitivity is suspected, appropriate tests should be performed and sensitivity ruled out prior to implantation
* Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation
* Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture
* Comminuted bone surface, which would compromise secure anchor fixation
* Hip subjects only:

* Dysplasia latera/central less than 20°
* Shoulder subjects only:

* Glenoid and/or humeral bone loss considered excessive by the treating orthopaedic surgeon
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Smith & Nephew Orthopaedics AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laura Everson

Role: STUDY_CHAIR

Smith & Nephew Ltd

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York University Langone Orthopaedic Center

New York, New York, United States

Site Status

Orthotennessee

Knoxville, Tennessee, United States

Site Status

CPH Privathospital

Farum, , Denmark

Site Status

Pihlajalinna Turku Hospital

Turku, , Finland

Site Status

Azienda Ospedaliera San Camillo Forlanini

Roma, , Italy

Site Status

Asepeyo Hospital Sant Cugat

Sant Cugat del Vallès, Barcelona, Spain

Site Status

Hospital Universitario Fundación Jiménez Díaz

Madrid, , Spain

Site Status

Queen Alexandra Hospital

Cosham, , United Kingdom

Site Status

Fortius Clinic

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Denmark Finland Italy Spain United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-5010-06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Avenir® Cemented Hip Stem - PMCF
NCT03396224 ACTIVE_NOT_RECRUITING